Related references
Note: Only part of the references are listed.Onco-nephrology: a decalogue
Laura Cosmai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
Matthew T. James et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study
Maurizio Montella et al.
BMC CANCER (2015)
Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomes
Daishi Ichioka et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: A systematic review
Francesco Cantiello et al.
INTERNATIONAL JOURNAL OF UROLOGY (2015)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Impact of the CKD-EPI Equation for Estimating Renal. Function on Eligibility for Cisplatin-based Chemotherapy in Patients With Urothelial Cancer
Che-Kai Tsao et al.
CLINICAL GENITOURINARY CANCER (2012)
Incidence of acute kidney injury in cancer patients: A Danish population-based cohort study
Christian Fynbo Christiansen et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2011)
Baseline Renal Function Status Limits Patient Eligibility to Receive Perioperative Chemotherapy for Invasive Bladder Cancer and Is Minimally Affected by Radical Cystectomy
Daniel Canter et al.
UROLOGY (2011)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Drug Management of Prostate Cancer: Prevalence and Consequences of Renal Insufficiency
Vincent Launay-Vacher et al.
CLINICAL GENITOURINARY CANCER (2009)
Chemotherapeutic options for cisplatin-ineligible patients with advanced carcinoma of the urothelium
David J. Vaughn
CANCER TREATMENT REVIEWS (2008)
Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer
James O. Jin et al.
CLINICAL GENITOURINARY CANCER (2006)
Prognosis of critically ill patients with cancer and acute renal dysfunction
Marcio Soares et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder
Atreya Dash et al.
CANCER (2006)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
J Coresh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
